Mercury Pharmaceuticals

We are de-risking biomedical innovations, while turning biomedical knowledge into social and economic value.

Stay Informed!

One brain implant could give people with paralysis a more expressive way to communicate

16

Sep 2026

One brain implant could give people with paralysis a more expressive way to communicate

Researchers showed that a single high-density ECoG implant could decode attempted speech and upper-body gestures in parallel in people with severe paralysis, allowing two participants to control a personalized full-body avatar. Training the decoders on both isolated and concurrent behaviors improved performance across contexts and reduced false activations, offering proof-of-concept evidence for more expressive multimodal BCIs.

Finnish adults eat too little of some foods and too much of others, study finds

16

Sep 2026

Finnish adults eat too little of some foods and too much of others, study finds

Analysis of dietary data from 1,655 Finnish adults found that usual food intake often differed substantially from the quantitative targets later set by the Nordic Nutrition Recommendations 2023. Plant-based foods were generally underconsumed, while red and processed meat and dairy intake frequently exceeded study targets, with adherence varying by sex, education, physical activity, age, and energy intake.

Exercise usually helps the brain. During a 15-day fast, the story was different

15

Sep 2026

Exercise usually helps the brain. During a 15-day fast, the story was different

In a 28-day controlled study of 22 healthy adults, 15 days of complete fasting produced a glucose-to-ketone metabolic shift and selectively affected attention and implicit learning while time perception remained relatively stable. Moderate-intensity exercise during early fasting was associated with poorer performance on some learning measures, while fasting also increased sleepiness and reduced calmness at some time points.

Male contraception has barely changed in a century. What comes next?

15

Sep 2026

Male contraception has barely changed in a century. What comes next?

A review traces more than 5,000 years of male contraception, from early penile sheaths and the development of modern condoms and vasectomy to today's search for reversible alternatives. Researchers are now testing hormonal gels, non-hormonal compounds and vas-occlusive technologies, although these approaches remain at different stages of preclinical and clinical development.

Summer program improves social skills in young autistic children

15

Sep 2026

Summer program improves social skills in young autistic children

A summer intervention program for autistic children ages 4-6 with no intellectual disability significantly improved their social performance, according to a study by researchers at the Institute for Autism Research (IAR) at the University at Buffalo. It was published in Advances in Neurodevelopmental Disorders in July.

Cannabis-derived nanovesicles showed early antitumor potential in mice

15

Sep 2026

Cannabis-derived nanovesicles showed early antitumor potential in mice

Researchers developed a Cannabis sativa hairy root culture system that produced stable plant-derived nanovesicles capable of promoting dendritic cell maturation and activating T-cell responses through TLR2- and TLR4-associated signaling. Oral administration also restored selected immune responses in immunosuppressed mice and suppressed tumor growth in an E.G7 lymphoma model, providing preliminary evidence for their immunomodulatory and antitumor potential.

MERCURY trials

Clinical trials are very important as it allow us to evaluate the effectiveness of new drugs, new devices, preventative strategies or treatment strategies. It also enables us to discover better ways for patients' care.
- Learn more

Cancer

Our mission remains constant as we endeavor to deliver novel medicines to patients with cancer, treating solid tumors with high unmet medical needs in well-defined patient populations that are currently not well supported.
- Learn more

Neuroscience

Whether you're looking to manufacture toxicology batches or cGMP material for clinical trials, we can help you expedite molecules to clinic with full transparency.
- Learn more

Mercury Pharmaceuticals

Why Us?

Strong experience in academic research and technology transfer makes us understand your goals and motivations as a technology originator.
Our experience in drug development from discovery to clinical and commercial stages makes us an insider player within the biopharmaceutical industry.
Smart approach to project management that helps speed up development stages and decision making.
Availability of own investment up to 2m€ per project allows us to reach the next value milestone.